GCI
14 FDA 510(k) clearances · Product code
93 daysmedian time to decision
271 days90th percentile
14clearances measured
FDA profile
- Official device name
- Laryngoscope, Endoscope
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 876.1500
- Medical specialty
- Gastroenterology, Urology
- Flags
- Third-party review eligible
- Adverse events (MAUDE)
- 2021: 96 · 2022: 102 · 2023: 101 · 2024: 119 · 2025: 122 · 2026: 59
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
Track GCI automatically
Every clearance here is in the API, with alerts when new ones post.